MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 15, 2006; DOI: 10.1124/mol.105.021170


0026-895X/06/6906-1861-1870$20.00
Mol Pharmacol 69:1861-1870, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.105.021170v1
69/6/1861    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kankaanranta, H.
Right arrow Articles by Moilanen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kankaanranta, H.
Right arrow Articles by Moilanen, E.

Antieosinophilic Activity of OraziponeFormula

Hannu Kankaanranta, Pinja Ilmarinen, Xianzhi Zhang, Erkki Nissinen, and Eeva Moilanen

The Immunopharmacology Research Group, Medical School, University of Tampere, Tampere, Finland (H.K., P.I., X.Z., E.M.); the Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China (X.Z.); Department of Respiratory Medicine (H.K.) and Research Unit (E.M.), Tampere University Hospital, Tampere, Finland; and OrionPharma Ltd., Espoo, Finland (E.N.)

Orazipone is a novel sulfhydryl-reactive compound that has been previously shown to reduce lung eosinophilia in guinea pigs and rats and to inhibit degranulation in mast cells and cytokine production in monocytes and T-cells. However, the effects of orazipone on granulocyte longevity are unknown. Orazipone and its derivative 3-(4-chloro-3-nitro-benzylidene)-pentane-2,4-dione (OR-2370) reversed interleukin-5-afforded survival of human eosinophils by inducing apoptosis. In contrast, orazipone did not affect granulocyte macrophage-colony-stimulating factor-induced survival of human neutrophils. The effect of orazipone on eosinophil apoptosis is different from that of glucocorticoids in that even high con-centrations of interleukin-5 were not able to overcome the effect of orazipone. Orazipone further enhanced spontaneous apoptosis as well as that induced by CD95 ligation without inducing primary necrosis. OR-2370-induced DNA fragmentation was shown to be dependent on caspases 3 and 6 and c-jun-N-terminal kinase, whereas extracellular regulated kinase, p38 mitogen-activated protein kinase, and phosphatidylinositol 3-kinase as well as caspases 4, 8, and 9 seem not to mediate its actions. Our results suggest that orazipone and its derivative OR-2370 possess strong antieosinophilic activity and thus may have anti-inflammatory efficacy in the treatment of asthma and/or allergic conditions.


Received November 25, 2005; accepted March 15, 2006

Address correspondence to: Dr. Hannu Kankaanranta, The Immunopharmacology Research Group, Medical School/B, FIN-33014 University of Tampere, Finland. E-mail: blhaka{at}uta.fi




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
O. Sareila, M. Hamalainen, E. Nissinen, H. Kankaanranta, and E. Moilanen
Orazipone Inhibits Activation of Inflammatory Transcription Factors Nuclear Factor-{kappa}B and Signal Transducer and Activator of Transcription 1 and Decreases Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production in Response to Inflammatory Stimuli
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 858 - 866.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Kankaanranta, X. Zhang, R. Tumelius, M. Ruotsalainen, H. Haikala, E. Nissinen, and E. Moilanen
Antieosinophilic Activity of Simendans
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 31 - 38.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics